(MENAFN- NewsBytes) Anti-malaria drug Hydroxychloroquine (HCQ) and anti-HIV drug combination lopinavir/ritonavir will no longer be explored as potential treatments for COVID-19 by the World Health Organization ( WHO ).
The WHO has discontinued the medicines' Solidarity trials after initial results showed they did not have any major benefit on hospitalized patients infected by the novel coronavirus.
Here's all you need to know about it.
In this article First, a bit about these drugs Solidarity trials with HCQ and other therapies Interim results showed no benefit Some safety signals also noted Trials to be discontinued with immediate effect Drugs First, a bit about these drugs
MENAFN0507202001650000ID1100434638
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.